Navigation Links
FDA Approves Stemedica IND for Ischemic Stroke Clinical Trial
Date:4/20/2010

Stemedica Cell Technologies, Inc. (Stemedica) announced that the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug (IND) for a clinical trial for ischemic stroke using Stemedica's high potency proprietary allogeneic stem cells (adult human).

San Diego, California (PRWEB) April 20, 2010 -- Stemedica Cell Technologies, Inc. (Stemedica), a world leader in stem cell research and manufacturing, announced that the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug (IND) for a clinical trial for ischemic stroke using Stemedica's high potency proprietary allogeneic stem cells (adult human).

“The FDA acceptance of our IND application and the clinical protocol for usage of allogeneic mesenchymal bone marrow-derived stem cells in subjects with ischemic stroke is an important milestone for Stemedica in its development program,” said Nikolai Tankovich, MD, PhD, Stemedica’s President and Chief Medical Officer. “Currently, patients suffering from ischemic stroke have very limited treatment options. We hope that bringing this novel option to the medical community will help to alleviate the burden of a serious and disabling disease and will be valuable for both patients and their family members.”

The IND application approval allows Stemedica to initiate a planned clinical trial at medical centers within the United States. The clinical trial will be a Phase I/II dose escalation and safety clinical trial using allogeneic mesenchymal bone marrow cells administered intravenously to patients with ischemic stroke. The patient population will include individuals with significant functional or neurologic impairment related to the ischemic stroke that confines the subject to a wheelchai
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. New York State Office of Mental Health Approves New High Performance Polycarbonate Sheet for Use in All Facilities
2. House of Representatives Approves Health-Care Reform Bill
3. Congress Approves Bill Curbing Internet Tobacco Sales in Victory for Kids and Taxpayers
4. New Jersey Approves Initiative to Expand the Number of Wound Care Certified Professionals
5. Golden Meditech Shareholders Approves of Name Change
6. The American Association of Anatomists approves guidelines for body donation programs
7. Kaiser Permanente Approves $170 Million in Community Benefit Grants in 2009
8. State Approves Certificate of Need for New PeaceHealth San Juan Island Hospital
9. A Christmas Gift for Eric: Senate Approves Health Care Bill in Historic Christmas Eve Vote
10. Medizone International, Inc. Approves Repurchase of Global Marketing Rights
11. FDA Approves First Additive Solution for Platelet Storage Up to 5 Days
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves Stemedica IND for Ischemic Stroke Clinical Trial
(Date:8/3/2015)... ... 2015 , ... Catalent Pharma Solutions, the leading global provider ... products, today welcomed the announcement by OPKO Health that the US Food and ... treatment for chronic kidney disease (CKD) and vitamin D insufficiency, which uses Catalent’s ...
(Date:8/3/2015)... Angeles, CA (PRWEB) , ... August 03, 2015 , ... ... dental services to help patients in need. Most people know that general health emergencies, ... emergency. Unfortunately, a fewer amount of people know where to turn to during a ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... industry-defining contract lifecycle management solution, as well as announced the date of its ... speed and ease of contract management tasks as well as enhancements to the ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... Physician Leadership ® and Navigant Center for Healthcare Research and Policy Analysis show ... Fifty-five percent of respondents said they agreed or strongly agreed that the controversial ...
(Date:8/3/2015)... ... August 03, 2015 , ... Sensato and ... Secure Healthcare Systems” This three-day, highly interactive and immersive workshop, has been ... access to the tactics, techniques and practices required to design and develop highly ...
Breaking Medicine News(10 mins):Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:Novatus Unveils Milestone Software Release 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4
... disorders (TD) was first described about 40 years ago. ... (PA) and Thyroiditis on the basis of gastric and ... on this frequently overlooked association. , A research article ... World Journal of Gastroenterology investigates the overlooked association. A ...
... with the annual,HIMSS healthcare IT conference, RemoteScan Corporation,( ... new pricing of,its popular RemoteScan(R) software. RemoteScan makes ... software to scan directly into any,medical document management ... or Windows Terminal Services servers. In addition to ...
... week Citi-Mobile,launched a new mobile billboard campaign to ... generously donated their mobile,billboards to the National Autism ... family assistance, and cutting-edge,research., The mobile billboards ... the cities of Glendale and Burbank. Kevin Bartanian, ...
... heart disease, study finds , , WEDNESDAY, Feb. 27 (HealthDay News) ... and adolescents with normal blood sugar levels had elevated markers ... for both type 2 diabetes and cardiovascular disease. , Researchers ... 10 to 18. Of those, 17 were lean and 21 ...
... WASHINGTON, Feb. 27 Following is the daily,Black History ... WEDNESDAY, FEBRUARY 27: INCOME & HEALTH INSURANCE, ... Month. The progress,of any segment of the U.S. population ... financial health. Recent figures show that the annual median ...
... Oriental,Bioengineering, Inc. (NYSE: AOB ), a leading manufacturer ... that,it plans to release fourth quarter and full year ... 2008 before the market opens., The Company will ... ET to,discuss results. Listeners may access the call by ...
Cached Medicine News:Health News:Does artificial intelligence help clinicians to recognize atrophic gastritis with thyroid disease? 2Health News:RemoteScan - Scanner Connectivity Software for EMR (Electronic Medical Record) Systems 2Health News:Overweight Hispanic Kids Show Early Markers for Diabetes 2Health News:American Oriental Bioengineering to Report Fourth Quarter and Full Year 2007 Financial Results 2
(Date:8/3/2015)... 2015  Sage Analytics ( www.sageanalytics.com ), the developers ... measurement systems, announced its sponsorship of the California Cannabis ... limited number of tickets are available for groups or ... cause while enjoying an open bar, buffet dinner and ... Francisco Bay at sunset. With the legislative ...
(Date:8/3/2015)... 2015 Global physiotherapy ... USD 24.7 billion by 2022, according to a ... prevalence of neurological and musculoskeletal disorders are expected ... forecast period. The presence of efficient and effective ... the technologies coupled with implementation of favorable government ...
(Date:8/3/2015)... Biosensors International Group, Ltd. ("Biosensors" or ... B20), a developer, manufacturer and marketer of innovative ... first fiscal quarter ended 30 June 2015 ("Q1 ... Developments: , Biosensors continued to ... driven by lower operating expenses and operational improvement. ...
Breaking Medicine Technology:Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 3Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 4Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 3Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 4Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 6
... contains primers and a FAM-labeled probe that ... (RSV). In addition, this ASR contains primers ... sample processing control. This ASR requires an ... Red reporter dyes such as the Cepheid ...
... primers and a FAM-labeled probe that is designed ... Staphylococcus protein A gene. In addition, this ASR ... for an internal control sequence. This ASR requires ... Red reporter dyes such as the Cepheid SmartCycler ...
Clot-based Assay for Anti-FXa and/or Anti-Iia Therapies...
Reptilase-Time from Bothrops atrox...
Medicine Products: